These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 19482086)

  • 61. The potential role of angiogenic factors in rheumatoid arthritis.
    Azizi G; Boghozian R; Mirshafiey A
    Int J Rheum Dis; 2014 May; 17(4):369-83. PubMed ID: 24467605
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pathophysiological mechanisms of angiogenesis.
    Walsh DA
    Adv Clin Chem; 2007; 44():187-221. PubMed ID: 17682343
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Anti-angiogenic therapy: Prospects for treatment of ocular tumors.
    Rosenblatt MI; Azar DT
    Semin Ophthalmol; 2006; 21(3):151-60. PubMed ID: 16912013
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Potential therapeutic implications of intracrine angiogenesis.
    Re RN; Cook JL
    Med Hypotheses; 2007; 69(2):414-21. PubMed ID: 17320306
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Targeting endothelial progenitor cells in cancer as a novel biomarker and anti-angiogenic therapy.
    Ammendola M; Leporini C; Luposella M; Sacco R; Sammarco G; Russo E; Patruno R; De Sarro G; Ranieri G
    Curr Stem Cell Res Ther; 2015; 10(2):181-7. PubMed ID: 25429701
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The history of the angiogenic switch concept.
    Ribatti D; Nico B; Crivellato E; Roccaro AM; Vacca A
    Leukemia; 2007 Jan; 21(1):44-52. PubMed ID: 16990761
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Advances in understanding angiogenesis through molecular studies.
    Kwon M; Libutti SK
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):26-32. PubMed ID: 16377412
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tumorigenesis and the angiogenic switch.
    Bergers G; Benjamin LE
    Nat Rev Cancer; 2003 Jun; 3(6):401-10. PubMed ID: 12778130
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tumor angiogenesis and anti-angiogenic therapy.
    Kubota Y
    Keio J Med; 2012; 61(2):47-56. PubMed ID: 22760023
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Anti-angiogenic activity of a novel class of chemopreventive compounds: oleanic acid terpenoids.
    Sogno I; Vannini N; Lorusso G; Cammarota R; Noonan DM; Generoso L; Sporn MB; Albini A
    Recent Results Cancer Res; 2009; 181():209-12. PubMed ID: 19213570
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antiangiogenic Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: Focusing on Regorafenib.
    Papadimitriou M; Papadimitriou CA
    Anticancer Res; 2021 Feb; 41(2):567-582. PubMed ID: 33517262
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Is copper chelation an effective anti-angiogenic strategy for cancer treatment?
    Antoniades V; Sioga A; Dietrich EM; Meditskou S; Ekonomou L; Antoniades K
    Med Hypotheses; 2013 Dec; 81(6):1159-63. PubMed ID: 24210000
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Angiopoietin inhibitors: A review on targeting tumor angiogenesis.
    Parmar D; Apte M
    Eur J Pharmacol; 2021 May; 899():174021. PubMed ID: 33741382
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Translating angiogenesis research into the clinic: the challenges ahead.
    Augustin HG
    Br J Radiol; 2003; 76 Spec No 1():S3-10. PubMed ID: 15456709
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of the angiogenesis signaling domain in pleiotrophin defines a mechanism of the angiogenic switch.
    Zhang N; Zhong R; Perez-Pinera P; Herradon G; Ezquerra L; Wang ZY; Deuel TF
    Biochem Biophys Res Commun; 2006 May; 343(2):653-8. PubMed ID: 16554021
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Extracellular Vesicle Membrane-Associated Proteins: Emerging Roles in Tumor Angiogenesis and Anti-Angiogenesis Therapy Resistance.
    Ko SY; Naora H
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751440
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Role of Angiogenic Growth Factors in Psoriasis: A Review.
    Akhtar T; Wani WY; Kamal MA; Kaur R
    Curr Drug Metab; 2018; 19(11):910-916. PubMed ID: 29663878
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Microtubule-targeting agents in angiogenesis: where do we stand?
    Pasquier E; Honoré S; Braguer D
    Drug Resist Updat; 2006; 9(1-2):74-86. PubMed ID: 16714139
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization.
    Fukumura D; Jain RK
    Microvasc Res; 2007; 74(2-3):72-84. PubMed ID: 17560615
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression.
    Shojaei F; Singh M; Thompson JD; Ferrara N
    Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2640-5. PubMed ID: 18268320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.